Cofar-ABR Syrup (100ml)
Terbutaline 1.25 mg + Acebrophylline 50 mg + Guaifenesin Syrup
| Composition | Terbutaline 1.25 mg + Acebrophylline 50 mg + Guaifenesin per 5 ml |
|---|---|
| Dosage Form | Oral Syrup |
| Pack Type | Bottle |
| Pack Size | 100 ml Bottle |
| MRP | ₹ 148.5 |
| Therapy | Paediatric + G.P. — Beta-2 Agonist + Mucolytic-Bronchodilator + Expectorant |
| Storage | Store below 30 °C in a dry place. Shake well before use. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Cofar-ABR Syrup (100ml)
Cofar-ABR Syrup combines Terbutaline 1.25 mg with Acebrophylline 50 mg and Guaifenesin per 5 ml. Acebrophylline is a unique mucolytic-bronchodilator (xanthine derivative + ambroxol salt) providing both mucolytic and bronchodilator action. Combined with Terbutaline’s bronchodilator effect and Guaifenesin’s expectorant action, this is a comprehensive bronchospastic-productive cough therapy.
Particularly useful in moderate asthma exacerbations, severe bronchitis with wheezing, and post-viral airway hyperreactivity in children. Acebrophylline is more potent than plain xanthines for mucolytic action.
Cofar-ABR is manufactured by Trumac Healthcare under WHO-GMP conditions. Available for monopoly-based PCD pharma franchise and third-party manufacturing — a specialty respiratory paediatric SKU.
Indications
- Moderate paediatric asthma exacerbations
- Severe bronchitis with wheezing
- Post-viral airway hyperreactivity
- Mucus-plugging bronchospastic cough
- Acute bronchiolitis (older infants)
Mechanism of Action
Terbutaline activates β2 receptors for bronchodilation. Acebrophylline provides mucolytic action plus weak phosphodiesterase inhibition. Guaifenesin enhances mucus clearance.
Dosage & Administration
Children 2–6 years: 2.5 ml three times daily. Children 6–12 years: 5 ml three times daily. Adults: 10 ml three times daily.
Side Effects
Tremor, palpitations, nausea, GI upset. Rare: tachycardia, hypokalaemia.
Contraindications & Precautions
Hypersensitivity. Tachyarrhythmias. Severe coronary disease. Acute peptic ulcer (acebrophylline caution).
Storage
Store below 30 °C in a dry place. Shake well before use.
Cofar-ABR Syrup (100ml) is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
What is Cofar-ABR used for?
Cofar-ABR contains Terbutaline + Acebrophylline + Guaifenesin. Used as per the indications described above.
How should Cofar-ABR be taken?
As directed by your physician. Complete the prescribed course.
Is Cofar-ABR available for PCD pharma franchise?
Yes, Trumac Healthcare offers Cofar-ABR on monopoly-based PCD pharma franchise and for third-party manufacturing.
How should Cofar-ABR be stored?
Store below 30 °C in a dry place, protected from light and moisture.
Is Cofar-ABR WHO-GMP certified?
Yes, manufactured in WHO-GMP and DCGI-compliant facilities.
Related Products
- Cofar-A Syrup (100ml) — Ambroxol HCl 15 mg + Terbutaline Sulphate 1.25 mg + Guaifenesin per 5 ml
- Cofar-A Drops — Terbutaline 0.25 mg + Ambroxol 3 mg + Guaifenesin 10 mg per ml